30 Sep 2020

CureVac begins Phase IIa trial of Covid-19 vaccine

CureVac has started dosing participants in a Phase IIa clinical trial of its messenger RNA (mRNA)-based Covid-19 vaccine candidate, CVnCoV. The dose-confirmation study, CV-NCOV-002, is being carried out in Peru…

30 Sep 2020

Regeneron trial finds Covid-19 therapy improved symptoms

A descriptive analysis of Regeneron Pharmaceuticals' Phase I/II/III clinical trial has found that its antibody cocktail REGN-COV2 lowered viral load and the time to symptoms improvement in non-hospitalised Covid-19 patients.…

29 Sep 2020

Innovent reports positive data of Tyvyt in HCC trial

Innovent Biologics has reported positive results from the Phase III ORIENT-32 clinical trial of a combination of Tyvyt (sintilimab) and Byvasda (bevacizumab or IBI305) in advanced hepatocellular carcinoma (HCC). Tyvyt…

29 Sep 2020

COVAXX begins Phase I trial of Covid-19 vaccine in Taiwan

COVAXX has started dosing healthy adult participants in a Phase I clinical trial of its Covid-19 vaccine candidate, UB-612, in Taiwan. The dose-escalation study received funds worth approximately $15m from…